Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy
Efficacy of Surgical Treatment of Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy
1 other identifier
observational
16
1 country
1
Brief Summary
The medical records of 16 eyes of 16 patients with macular hole retinal detachment or myopic traction maculopathy who received viterctomy including internal limiting membrane peeling and scleral shorting surgery were reviewed. Best-corrected visual acuity, axial length, retinal reattachment and macular hole closure, the shape of staphyloma determined by optical coherence tomography and 3-dimensional magnetic resonance imaging were assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 16, 2015
CompletedFirst Posted
Study publicly available on registry
August 19, 2015
CompletedAugust 19, 2015
August 1, 2015
2.1 years
August 16, 2015
August 18, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual acuity before and after surgery
Comparison with logarithm of Minimum Angle of Resolution (logMAR) vision
6 months
Secondary Outcomes (1)
Retinal reattachment
6 months
Interventions
Eligibility Criteria
The patients who underwent vitrectomy with scleral shortening for macular hole retinal detachment or myopic traction maculopathy
You may not qualify if:
- The patients with follow-up less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Makoto Inoue
Mitaka, Tokyo, 181-8611, Japan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Akito Hirakata, MD
Kyorin Eye Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Kyorin Eye Center
Study Record Dates
First Submitted
August 16, 2015
First Posted
August 19, 2015
Study Start
June 1, 2012
Primary Completion
July 1, 2014
Study Completion
June 1, 2015
Last Updated
August 19, 2015
Record last verified: 2015-08